Gordian E - Search Results

1

Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity.

Gordian E, Ramachandran K, Singal R. Gordian E, et al. Anticancer Res. 2009 Aug;29(8):3207-10. Anticancer Res. 2009. PMID: 19661336 Free article.

2

Methylation-mediated silencing of genes is not altered by selenium treatment of prostate cancer cells.

Ramachandran K, Navarro L, Gordian E, Das PM, Singal R. Ramachandran K, et al. Among authors: gordian e. Anticancer Res. 2007 Mar-Apr;27(2):921-5. Anticancer Res. 2007. PMID: 17465221 Free article.

3

Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.

Ramachandran K, Gopisetty G, Gordian E, Navarro L, Hader C, Reis IM, Schulz WA, Singal R. Ramachandran K, et al. Among authors: gordian e. Cancer Res. 2009 Feb 15;69(4):1527-35. doi: 10.1158/0008-5472.CAN-08-3609. Epub 2009 Feb 3. Cancer Res. 2009. PMID: 19190346

4

Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity.

Ramachandran K, Miller H, Gordian E, Rocha-Lima C, Singal R. Ramachandran K, et al. Among authors: gordian e. Anticancer Res. 2010 Oct;30(10):3919-25. Anticancer Res. 2010. PMID: 21036703

5

5-azacytidine reverses drug resistance in bladder cancer cells.

Ramachandran K, Gordian E, Singal R. Ramachandran K, et al. Among authors: gordian e. Anticancer Res. 2011 Nov;31(11):3757-66. Anticancer Res. 2011. PMID: 22110197

6

Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy.

Singal R, Ramachandran K, Gordian E, Quintero C, Zhao W, Reis IM. Singal R, et al. Among authors: gordian e. Clin Genitourin Cancer. 2015 Feb;13(1):22-31. doi: 10.1016/j.clgc.2014.07.008. Epub 2014 Aug 1. Clin Genitourin Cancer. 2015. PMID: 25178642 Clinical Trial.

7

Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease.

Reis IM, Ramachandran K, Speer C, Gordian E, Singal R. Reis IM, et al. Among authors: gordian e. Br J Cancer. 2015 Jul 28;113(3):460-8. doi: 10.1038/bjc.2015.240. Epub 2015 Jul 14. Br J Cancer. 2015. PMID: 26171936 Free PMC article.

8

Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate disease.

Gordian E, Ramachandran K, Reis IM, Manoharan M, Soloway MS, Singal R. Gordian E, et al. Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1984-91. doi: 10.1158/1055-9965.EPI-10-0287. Epub 2010 Jul 20. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20647404

9

Transforming growth factor β signaling overcomes dasatinib resistance in lung cancer.

Gordian E, Li J, Pevzner Y, Mediavilla-Varela M, Luddy K, Ohaegbulam K, Daniel KG, Haura EB, Muñoz-Antonia T. Gordian E, et al. PLoS One. 2014 Dec 11;9(12):e114131. doi: 10.1371/journal.pone.0114131. eCollection 2014. PLoS One. 2014. PMID: 25501935 Free PMC article.

10

CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell lines.

Wright GM, Gimbrone NT, Sarcar B, Percy TR, Gordián ER, Kinose F, Sumi NJ, Rix U, Cress WD. Wright GM, et al. Among authors: gordian er. PLoS One. 2021 Jun 17;16(6):e0252927. doi: 10.1371/journal.pone.0252927. eCollection 2021. PLoS One. 2021. PMID: 34138895 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters